FSTL3 and neoplasm: Following implantation intraperitoneally at 1.10^6 cells/mouse, we observed that FSTL3 overexpression led to a 50% higher tumor mass in mice compared to the KPCA.FSTKO cells at day 10 post-graft (Fig. 4A).